Health-care companies fell as traders rotated into more cyclical sectors.

The Trump administration has named the five drug developers it expects to be the most likely to produce a viable Covid-19 vaccine, in a sign it's set to consolidate federal support behind these companies, The New York Times reported.

Those vaccine developers are Britain's AstraZeneca, in combination with Oxford University; Johnson & Johnson; Moderna; Merck; and Pfizer, in combination with BioNTech. Shares of Moderna, AstraZeneca and Johnson & Johnson rose slightly.

Write to Rob Curran at rob.curran@dowjones.com